Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.24.2.u1
Revenue from Contracts with Customers (Tables)
12 Months Ended
Mar. 31, 2024
Disclosure of disaggregation of revenue from contracts with customers [abstract]  
Schedule of Disaggregation of Revenue from Contracts with Customers

The principal revenue activities of the Company for the years ended March 31, 2024, 2023 and 2022 were as follows:

 

 

 

For the Year Ended March 31,

 

Revenue categories

 

2024

 

 

2023

 

 

2022

 

Revenue from ViraxClear

 

 

156,419

 

 

 

8,561

 

 

 

 

Total Revenue

 

$

156,419

 

 

$

8,561

 

 

$